{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:22:04Z","timestamp":1788463324417,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) is characterized by reproductive and metabolic disturbances and associated with higher prevalence of anxiety and depression. Circulating adiponectin, an insulin-sensitizing adipokine, is reduced in women with PCOS, and low adiponectin has been linked to impaired mental health, particularly in females. We investigated whether low serum adiponectin is associated with impaired mental health in women with PCOS and whether adiponectin deficiency exacerbates anxiety-like behaviour in a PCOS-like mouse model. Serum adiponectin was measured in women with (n\u2009=\u2009179) and without PCOS (n\u2009=\u2009228), stratified by body mass index (BMI). Health-related quality of life was assessed using the short form 36 (SF-36), generating physical and mental component scores. In parallel, the prenatal androgenization (PNA) PCOS-like mouse model was combined with adiponectin-deficient mice (APNhet) to assess the impact of reduced adiponectin on anxiety-like behaviour with and without prenatal androgen exposure. Women with PCOS had lower total and high molecular weight adiponectin levels compared with controls. Adiponectin positively correlated with mental component scores in women with BMI\u2009&lt;\u200930, but not in those with obesity. Free testosterone was inversely correlated with adiponectin. In mice, PNA induced anxiety-like behaviour. However, despite a 65% reduction in serum adiponectin levels in APNhet PNA mice, adiponectin deficiency did not exacerbate the anxiety-like phenotype. Unlike women with PCOS, adult PNA mice were not hyperandrogenic. These findings suggest that adiponectin is associated with mental health in non-obese women, but reduced adiponectin alone does not induce anxiety-like behaviour in the absence of hyperandrogenism. Further studies in hyperandrogenic models are needed to clarify how adiponectin and hyperandrogenism interact across developmental stages and in different BMI groups to influence vulnerability to anxiety and depression in PCOS.<\/jats:p>\n                  <jats:p>Trial registration<\/jats:p>\n                  <jats:p>Clinical trial.gov: NCT01319162, NCT00484705, NCT01457209, and NCT00921492.<\/jats:p>","DOI":"10.1038\/s41598-026-69143-9","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:57:04Z","timestamp":1788454624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoadiponectinemia does not enhance anxiety-like behaviour in a lean PCOS-like mouse model"],"prefix":"10.1038","volume":"16","author":[{"given":"Manisha","family":"Samad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Wernstedt Asterholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Stener-Victorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Benrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"69143_CR1","unstructured":"Teede, H. International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023. Monash University: Melbourne, Australia. (2023)."},{"key":"69143_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00511-3","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin, E. et al. Polycystic ovary syndrome. Nat. Rev. Dis. Primershttps:\/\/doi.org\/10.1038\/s41572-024-00511-3 (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"69143_CR3","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede, H. J. et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J. Clin. Endocrinol. Metab.108(10), 2447\u20132469 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"69143_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.fertnstert.2024.01.018","volume":"121","author":"S Alur-Gupta","year":"2024","unstructured":"Alur-Gupta, S., Dokras, A. & Cooney, L. G. Management of polycystic ovary syndrome must include assessment and treatment of mental health symptoms. Fertil. Steril.121(3), 384\u2013399 (2024).","journal-title":"Fertil. Steril."},{"issue":"7","key":"69143_CR5","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/j.fertnstert.2009.09.018","volume":"93","author":"AA Deeks","year":"2010","unstructured":"Deeks, A. A., Gibson-Helm, M. E. & Teede, H. J. Anxiety and depression in polycystic ovary syndrome: A comprehensive investigation. Fertil. Steril.93(7), 2421\u20132423 (2010).","journal-title":"Fertil. Steril."},{"issue":"3","key":"69143_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00737-024-01526-1","volume":"28","author":"M Infante-Cano","year":"2025","unstructured":"Infante-Cano, M. et al. The prevalence and risk of anxiety and depression in polycystic ovary syndrome: An overview of systematic reviews with meta-analysis. Arch. Womens Ment. Health28(3), 475\u2013489 (2025).","journal-title":"Arch. Womens Ment. Health"},{"key":"69143_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2025.1520641","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. Analysis of risk factors for depression and anxiety in women with polycystic ovary syndrome. Front. Glob. Women\u2019s Healthhttps:\/\/doi.org\/10.3389\/fgwh.2025.1520641 (2025).","journal-title":"Front. Glob. Women's Health"},{"issue":"5","key":"69143_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","volume":"32","author":"LG Cooney","year":"2017","unstructured":"Cooney, L. G. et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: A systematic review and meta-analysis. Hum. Reprod.32(5), 1075\u20131091 (2017).","journal-title":"Hum. Reprod."},{"issue":"5","key":"69143_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/09513590312331290268","volume":"17","author":"S Coffey","year":"2003","unstructured":"Coffey, S. & Mason, H. The effect of polycystic ovary syndrome on health-related quality of life. Gynecol. Endocrinol.17(5), 379\u2013386 (2003).","journal-title":"Gynecol. Endocrinol."},{"issue":"2","key":"69143_CR10","first-page":"673","volume":"25","author":"S Eggers","year":"2001","unstructured":"Eggers, S. & Kirchengast, S. The polycystic ovary syndrome\u2013a medical condition but also an important psychosocial problem. Coll. Antropol.25(2), 673\u2013685 (2001).","journal-title":"Coll. Antropol."},{"issue":"6","key":"69143_CR11","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2005-1494","volume":"91","author":"JM Vink","year":"2006","unstructured":"Vink, J. M. et al. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab.91(6), 2100\u20132104 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"69143_CR12","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/humrep\/deab119","volume":"36","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Deng, Q. & Stener-Victorin, E. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: Evidence from a comprehensive genetic analysis. Hum. Reprod.36(8), 2382\u20132391 (2021).","journal-title":"Hum. Reprod."},{"issue":"4","key":"69143_CR13","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1210\/endrev\/bnaa010","volume":"41","author":"E Stener-Victorin","year":"2020","unstructured":"Stener-Victorin, E. et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr. Rev.41(4), 538\u2013576 (2020).","journal-title":"Endocr. Rev."},{"key":"69143_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1273542","author":"K Wang","year":"2023","unstructured":"Wang, K., Li, Y. & Chen, Y. Androgen excess: A hallmark of polycystic ovary syndrome. Front. Endocrinol.https:\/\/doi.org\/10.3389\/fendo.2023.1273542 (2023).","journal-title":"Front. Endocrinol."},{"issue":"10","key":"69143_CR15","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","volume":"17","author":"T Sir-Petermann","year":"2002","unstructured":"Sir-Petermann, T. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: Possible implications in prenatal androgenization. Hum. Reprod.17(10), 2573\u20132579 (2002).","journal-title":"Hum. Reprod."},{"key":"69143_CR16","doi-asserted-by":"crossref","unstructured":"David, et al. In utero Androgen Excess: A Developmental Commonality Preceding Polycystic Ovary Syndrome?, S. Karger AG. p. 1\u201317. (2019).","DOI":"10.1159\/000494899"},{"key":"69143_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01183-9","author":"S Risal","year":"2021","unstructured":"Risal, S. et al. Prenatal androgen exposure causes a sexually dimorphic transgenerational increase in offspring susceptibility to anxiety disorders. Transl. Psychiatryhttps:\/\/doi.org\/10.1038\/s41398-020-01183-9 (2021).","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"69143_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1017\/S0033291719000424","volume":"50","author":"CE Cesta","year":"2020","unstructured":"Cesta, C. E. et al. Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: Prenatal androgen exposure or genetic confounding?. Psychol. Med.50(4), 616\u2013624 (2020).","journal-title":"Psychol. Med."},{"issue":"7","key":"69143_CR19","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1172\/JCI29126","volume":"116","author":"T Kadowaki","year":"2006","unstructured":"Kadowaki, T. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest.116(7), 1784\u20131792 (2006).","journal-title":"J. Clin. Invest."},{"key":"69143_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2022.105927","volume":"146","author":"IT Johansen","year":"2022","unstructured":"Johansen, I. T. et al. Sex-specific associations between metabolic hormones, severe mental disorders and antipsychotic treatment. Psychoneuroendocrinology146, 105927 (2022).","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"69143_CR21","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1007\/s13277-013-1595-0","volume":"35","author":"S Li","year":"2014","unstructured":"Li, S. et al. Low circulating adiponectin levels in women with polycystic ovary syndrome: An updated meta-analysis. Tumor Biol.35(5), 3961\u20133973 (2014).","journal-title":"Tumor Biol."},{"key":"69143_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17919-5","author":"M Kokosar","year":"2018","unstructured":"Kokosar, M. et al. A single bout of electroacupuncture remodels epigenetic and transcriptional changes in adipose tissue in polycystic ovary syndrome. Sci. Rep.https:\/\/doi.org\/10.1038\/s41598-017-17919-5 (2018).","journal-title":"Sci. Rep."},{"key":"69143_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jad.2019.09.050","volume":"260","author":"E Vuong","year":"2020","unstructured":"Vuong, E. et al. Peripheral adiponectin levels in anxiety, mood, trauma- and stressor-related disorders: A systematic review and meta-analysis. J. Affect. Disord.260, 372\u2013409 (2020).","journal-title":"J. Affect. Disord."},{"issue":"8","key":"69143_CR24","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/en.2014-1196","volume":"155","author":"ASL Caldwell","year":"2014","unstructured":"Caldwell, A. S. L. et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology155(8), 3146\u20133159 (2014).","journal-title":"Endocrinology"},{"issue":"8","key":"69143_CR25","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1096\/fj.201601381R","volume":"31","author":"A Benrick","year":"2017","unstructured":"Benrick, A. et al. Autonomic nervous system activation mediates the increase in whole-body glucose uptake in response to electroacupuncture. FASEB J.31(8), 3288\u20133297 (2017).","journal-title":"FASEB J."},{"issue":"2","key":"69143_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/humrep\/dep384","volume":"25","author":"E Jedel","year":"2010","unstructured":"Jedel, E. et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum. Reprod.25(2), 450\u2013456 (2010).","journal-title":"Hum. Reprod."},{"issue":"9","key":"69143_CR27","doi-asserted-by":"publisher","first-page":"E934","DOI":"10.1152\/ajpendo.00039.2013","volume":"304","author":"J Johansson","year":"2013","unstructured":"Johansson, J. et al. Acupuncture for ovulation induction in polycystic ovary syndrome: A randomized controlled trial. Am. J. Physiol. Endocrinol. Metab.304(9), E934\u2013E943 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"69143_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/cen.14098","volume":"91","author":"J Kataoka","year":"2019","unstructured":"Kataoka, J. et al. Prevalence of polycystic ovary syndrome in women with severe obesity - Effects of a structured weight loss programme. Clin. Endocrinol. (Oxf)91(6), 750\u2013758 (2019).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"69143_CR29","doi-asserted-by":"publisher","first-page":"13495","DOI":"10.1038\/s41598-024-63166-w","volume":"14","author":"J Kataoka","year":"2024","unstructured":"Kataoka, J. et al. Effects of weight loss intervention on anxiety, depression and quality of life in women with severe obesity and polycystic ovary syndrome. Sci. Rep.14(1), 13495 (2024).","journal-title":"Sci. Rep."},{"issue":"18","key":"69143_CR30","doi-asserted-by":"publisher","first-page":"18073","DOI":"10.1074\/jbc.M414231200","volume":"280","author":"A Xu","year":"2005","unstructured":"Xu, A. et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J. Biol. Chem.280(18), 18073\u201318080 (2005).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"69143_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/JME-13-0201","volume":"52","author":"G Capllonch-Amer","year":"2014","unstructured":"Capllonch-Amer, G. et al. Opposite effects of 17-beta estradiol and testosterone on mitochondrial biogenesis and adiponectin synthesis in white adipocytes. J. Mol. Endocrinol.52(2), 203\u2013214 (2014).","journal-title":"J. Mol. Endocrinol."},{"key":"69143_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06154-8","author":"P Keeratibharat","year":"2024","unstructured":"Keeratibharat, P. et al. Prevalence of depression and anxiety in women with polycystic ovary syndrome (PCOS) and associated factors in a quaternary hospital in Thailand: A cross-sectional study. BMC Psychiatryhttps:\/\/doi.org\/10.1186\/s12888-024-06154-8 (2024).","journal-title":"BMC Psychiatry"},{"key":"69143_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/IJWH.S165794","volume":"10","author":"Z Behboodi Moghadam","year":"2018","unstructured":"Behboodi Moghadam, Z. et al. Measures of health-related quality of life in PCOS women: A systematic review. Int. J. Womens Health10, 397\u2013408 (2018).","journal-title":"Int. J. Womens Health"},{"issue":"4","key":"69143_CR34","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s13760-017-0798-3","volume":"117","author":"HR Martinez","year":"2017","unstructured":"Martinez, H. R. et al. CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis. Acta Neurol. Belg.117(4), 879\u2013883 (2017).","journal-title":"Acta Neurol. Belg."},{"key":"69143_CR35","doi-asserted-by":"crossref","unstructured":"Ryberg, H., et al., Sex steroid levels in corresponding cerebrospinal fluid and serum samples quantified by mass spectrometry in men. Endocrine Connections. 13(1). (2023).","DOI":"10.1530\/EC-23-0250"},{"issue":"5","key":"69143_CR36","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1074\/jbc.M505311200","volume":"281","author":"AR Nawrocki","year":"2006","unstructured":"Nawrocki, A. R. et al. Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor \u03b3 Agonists. J. Biol. Chem.281(5), 2654\u20132660 (2006).","journal-title":"J. Biol. Chem."},{"key":"69143_CR37","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10565","author":"I R\u0103dulescu","year":"2021","unstructured":"R\u0103dulescu, I. et al. Neuroplasticity and depression: Rewiring the brain\u2019s networks through pharmacological therapy (review). Exp. Ther. Med.https:\/\/doi.org\/10.3892\/etm.2021.10565 (2021).","journal-title":"Exp. Ther. Med."},{"issue":"6 Suppl","key":"69143_CR38","doi-asserted-by":"publisher","first-page":"588S","DOI":"10.1080\/07315724.2004.10719428","volume":"23","author":"DJ Barker","year":"2004","unstructured":"Barker, D. J. The developmental origins of adult disease. J. Am. Coll. Nutr.23(6 Suppl), 588S-595S (2004).","journal-title":"J. Am. Coll. Nutr."},{"issue":"12","key":"69143_CR39","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","volume":"25","author":"S Risal","year":"2019","unstructured":"Risal, S. et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat. Med.25(12), 1894\u20131904 (2019).","journal-title":"Nat. Med."},{"issue":"6","key":"69143_CR40","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1210\/jc.2008-2836","volume":"94","author":"T Sir-Petermann","year":"2009","unstructured":"Sir-Petermann, T. et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab.94(6), 1923\u20131930 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"69143_CR41","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/humrep\/dem090","volume":"22","author":"T Sir-Petermann","year":"2007","unstructured":"Sir-Petermann, T. et al. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum. Reprod.22(7), 1830\u20131836 (2007).","journal-title":"Hum. Reprod."},{"issue":"9","key":"69143_CR42","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.3390\/ijms23094939","volume":"23","author":"M Mohan Shrestha","year":"2022","unstructured":"Mohan Shrestha, M. et al. Adiponectin deficiency alters placenta function but does not affect fetal growth in mice. Int. J. Mol. Sci.23(9), 4939 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"69143_CR43","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.2337\/db12-0055","volume":"61","author":"L Qiao","year":"2012","unstructured":"Qiao, L. et al. Adiponectin enhances mouse fetal fat deposition. Diabetes61(12), 3199\u20133207 (2012).","journal-title":"Diabetes"},{"issue":"9","key":"69143_CR44","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.3390\/nu12092735","volume":"12","author":"CE Orsso","year":"2020","unstructured":"Orsso, C. E. et al. Adipose tissue development and expansion from the womb to adolescence: An overview. Nutrients12(9), 2735 (2020).","journal-title":"Nutrients"},{"issue":"6","key":"69143_CR45","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/humrep\/deae066","volume":"39","author":"C Vatier","year":"2024","unstructured":"Vatier, C. & Christin-Maitre, S. Epigenetic\/circadian clocks and PCOS. Hum. Reprod.39(6), 1167\u20131175 (2024).","journal-title":"Hum. Reprod."},{"issue":"11","key":"69143_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027286","volume":"6","author":"N Xu","year":"2011","unstructured":"Xu, N. et al. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS ONE6(11), e27286 (2011).","journal-title":"PLoS ONE"},{"issue":"1","key":"69143_CR47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41380-018-0102-9","volume":"24","author":"F Sun","year":"2019","unstructured":"Sun, F. et al. Adiponectin modulates ventral tegmental area dopamine neuron activity and anxiety-related behavior through AdipoR1. Mol. Psychiatry24(1), 126\u2013144 (2019).","journal-title":"Mol. Psychiatry"},{"key":"69143_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.178468","volume":"1011","author":"Y Li","year":"2026","unstructured":"Li, Y. et al. AdipoRon ameliorates anxiety- and depression-like behaviors in chronic restraint-stressed mice via AMPK-PPARalpha-BDNF-TrkB signaling. Eur. J. Pharmacol.1011, 178468 (2026).","journal-title":"Eur. J. Pharmacol."},{"key":"69143_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020249","author":"DA Formolo","year":"2023","unstructured":"Formolo, D. A. et al. Increasing adiponectin signaling by sub-chronic adipoRon treatment elicits antidepressant- and anxiolytic-like effects independent of changes in hippocampal plasticity. Biomedicineshttps:\/\/doi.org\/10.3390\/biomedicines11020249 (2023).","journal-title":"Biomedicines"},{"issue":"8","key":"69143_CR50","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1038\/s41380-020-0649-0","volume":"26","author":"C Li","year":"2021","unstructured":"Li, C. et al. Modulation of depression-related behaviors by adiponectin AdipoR1 receptors in 5-HT neurons. Mol. Psychiatry26(8), 4205\u20134220 (2021).","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"69143_CR51","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1073\/pnas.1500877112","volume":"112","author":"A Kleinridders","year":"2015","unstructured":"Kleinridders, A. et al. Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc. Natl. Acad. Sci. U. S. A.112(11), 3463\u20133468 (2015).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"69143_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101234","volume":"52","author":"JL Milstein","year":"2021","unstructured":"Milstein, J. L. & Ferris, H. A. The brain as an insulin-sensitive metabolic organ. Mol. Metab.52, 101234 (2021).","journal-title":"Mol. Metab."},{"issue":"7","key":"69143_CR53","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.2337\/db13-1954","volume":"63","author":"FG De Felice","year":"2014","unstructured":"De Felice, F. G. & Ferreira, S. T. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes63(7), 2262\u20132272 (2014).","journal-title":"Diabetes"},{"issue":"2","key":"69143_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1677\/JOE-10-0217","volume":"207","author":"AV Roland","year":"2010","unstructured":"Roland, A. V. et al. Prenatal androgen exposure programs metabolic dysfunction in female mice. J. Endocrinol.207(2), 213\u2013223 (2010).","journal-title":"J. Endocrinol."},{"key":"69143_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155716","volume":"151","author":"M Bauz\u00e1-Thorbr\u00fcgge","year":"2024","unstructured":"Bauz\u00e1-Thorbr\u00fcgge, M. et al. Adiponectin stimulates Sca1+CD34\u2212-adipocyte precursor cells associated with hyperplastic expansion and beiging of brown and white adipose tissue. Metabolism151, 155716 (2024).","journal-title":"Metabolism"},{"issue":"3","key":"69143_CR56","doi-asserted-by":"publisher","first-page":"E529","DOI":"10.1152\/ajpendo.00128.2020","volume":"319","author":"JD Botezelli","year":"2020","unstructured":"Botezelli, J. D. et al. Adipose depot-specific upregulation of Ucp1 or mitochondrial oxidative complex proteins are early consequences of genetic insulin reduction in mice. Am. J. Physiol. Endocrinol. Metab.319(3), E529\u2013E539 (2020).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"69143_CR57","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12020-023-03436-1","volume":"82","author":"K Stefanaki","year":"2023","unstructured":"Stefanaki, K. et al. Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome. Endocrine82(1), 201\u2013208 (2023).","journal-title":"Endocrine"},{"issue":"2-3","key":"69143_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0165-0327(00)00242-1","volume":"64","author":"P Svanborg","year":"2001","unstructured":"Svanborg, P. & Asberg, M. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS). J. Affect. Disord.64(2\u20133), 203\u2013216 (2001).","journal-title":"J. Affect. Disord."},{"issue":"1","key":"69143_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0447.1994.tb01480.x","volume":"89","author":"P Svanborg","year":"1994","unstructured":"Svanborg, P. & \u00c5sberg, M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr. Scand.89(1), 21\u201328 (1994).","journal-title":"Acta Psychiatr. Scand."},{"issue":"11","key":"69143_CR60","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","volume":"51","author":"JE Ware","year":"1998","unstructured":"Ware, J. E. & Gandek, B. Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project. J. Clin. Epidemiol.51(11), 903\u2013912 (1998).","journal-title":"J. Clin. Epidemiol."},{"issue":"10","key":"69143_CR61","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen, A., Verdonck, L. & Kaufman, J. M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab.84(10), 3666\u20133672 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"69143_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100684","volume":"2","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni, N. E. H. & Giacobini, P. Polycystic ovary syndrome mouse model by prenatal exposure to high anti-M\u00fcllerian hormone. STAR Protoc.2(3), 100684 (2021).","journal-title":"STAR Protoc."},{"issue":"34","key":"69143_CR63","doi-asserted-by":"publisher","first-page":"E7187","DOI":"10.1073\/pnas.1708854114","volume":"114","author":"A Benrick","year":"2017","unstructured":"Benrick, A. et al. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model. Proc. Natl. Acad. Sci. U. S. A.114(34), E7187\u2013E7196 (2017).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"69143_CR64","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/jcbfm.2014.255","volume":"35","author":"CJ Ek","year":"2015","unstructured":"Ek, C. J. et al. Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia. J. Cereb. Blood Flow Metab.35(5), 818\u2013827 (2015).","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"69143_CR65","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1210\/en.2014-1890","volume":"156","author":"ME Nilsson","year":"2015","unstructured":"Nilsson, M. E. et al. Measurement of a comprehensive sex steroid profile in rodent serum by high-sensitive gas chromatography-tandem mass spectrometry. Endocrinology156(7), 2492\u20132502 (2015).","journal-title":"Endocrinology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-69143-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-69143-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-69143-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:02:09Z","timestamp":1788462129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-69143-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69143"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-69143-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27688"}}